Simplifying Global Compliance
FDAnews Drug Daily Bulletin
GSK Drug Halves Attacks in Hard-to-Treat Asthma
Aug. 20, 2012
An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing